At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
In Brief
A clinical study evaluating Bimatoprost 0.01% and Placebo: saline for Nail Growth Cessation and Intraocular Pressure. Completed, enrolled 45 participants across 1 site.
Detailed Summary
Topical prostaglandin agents are used to help reduce eye pressure in glaucoma patients. Bimatoprost (Lumigan 0.01%) is such an agent (Allergan, Inc.). Several of our patients on bimatoprost and an observational study of patients on bimatoprost in another center reported that fingernails grew longer and became less brittle using the topical eye drops to the eyes. The purpose of the double-blinded study is to determine whether the application of the eye drops directly to the proximal nail fold of one hand using the opposite hand as a control will result in longer nails, less brittle nails, and reduced eye pressures should any of the medication be absorbed into the systemic circulation.
Study Details
Timeline
Interventions
Bimatoprost drops added to the proximal nail folds of the randomized study hand digits two times per day for 30 days
Placebo drops added to the proximal nail folds of the hand digits opposite the study hand two times per day for 30 days